Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

6,042 total articles

Nebius Needs Perfection to Justify a $57B Valuation

Nebius Needs Perfection to Justify a $57B Valuation

Nebius has re-rated into a hefty $57.4B market cap on blockbuster growth prints and headline customer commitments. That story is real, but the market is pricing nearly flawless delivery of multibillion-dollar deals across a capital-intensive buildout. We recommend a tactical short against a bounce: entry $235, stop $275, target $160 over a mid-term…

Lantronix Could Be the AI-Drone Re-rate Stock the Market Has Overlooked

Lantronix Could Be the AI-Drone Re-rate Stock the Market Has Overlooked

Lantronix (LTRX) is building a credible pathway into the high-growth Edge AI and drone markets via multi-silicon platform deals, Teledyne FLIR integrations and new Wi‑Fi 6 production modules. With a compact market cap (~$261M), positive free cash flow and tight short-interest dynamics, LTRX looks positioned for a near-term re-rate. This trade propo…

BOIVF: Activist Heat + Heavy Shorts Creates a Tactical Long Opportunity

BOIVF: Activist Heat + Heavy Shorts Creates a Tactical Long Opportunity

BOLLORE INVESTISSEMNT ORD (BOIVF) is trading above its short- and mid-term averages, sees outsized short activity, and — according to market chatter — may be the focus of activist interest from Bill Ackman. The combination of a technical setup, compressed float, and episodic short covering makes a mid-term long (45 trading days) an actionable trade…

Medtronic: Quiet Turnaround Showing Traction - Mid-Term Trade Idea

Medtronic: Quiet Turnaround Showing Traction - Mid-Term Trade Idea

Medtronic's latest quarter showed durable top-line momentum across Cardiovascular and Diabetes while one-off items compressed margins. The fundamentals and cash flow support a buy here; technicals show constructive momentum. This is a mid-term swing trade that leans on continued margin normalization and Diabetes product tailwinds.

Arteris: Small NoC IP Player Positioned to Ride the AI Chip Wave

Arteris: Small NoC IP Player Positioned to Ride the AI Chip Wave

Arteris (AIP) is a niche network-on-chip (NoC) IP vendor that has quietly earned design wins with AMD, Li Auto and other AI and automotive chip customers. The stock has run up from its 2025 lows, but current pullbacks create a defined-risk entry into a company that could see meaningful revenue leverage as hyperscalers and chipmakers adopt chiplet a…

CoreWeave: Booked-Out Growth, Underpriced Optionality

CoreWeave: Booked-Out Growth, Underpriced Optionality

CoreWeave has validated next-gen Nvidia racks and sits on a reported $99.4B backlog while Nvidia has increased its stake to roughly 9%. The market is punishing the stock for leverage and negative cash flow, leaving an entry opportunity for disciplined, risk-aware longs. This trade idea lays out an entry at $100.40, a stop at $82.00 and a mid-term t…